The latest quarterly R&D expense is $2.52 Million with a QoQ Growth of +7.51%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $2.52M.
$2.52M
$2.52 Million
Q2 FY2026 · 2026-06-30
+7.51%
vs. $2.34M prior quarter
23
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $2.52M | +7.51% | +143.01% |
| Q1 FY2026Period end 2026-03-31 | $2.34M | +6.55% | -3.58% |
| Q4 FY2025Period end 2025-12-31 | $2.20M | +18.92% | -19.65% |
| Q3 FY2025Period end 2025-09-30 | $1.85M | +78.40% | -20.80% |
| Q2 FY2025Period end 2025-06-30 | $1.04M | -57.34% | -55.57% |
| Q1 FY2025Period end 2025-03-31 | $2.43M | -11.21% | +43.25% |
| Q4 FY2024Period end 2024-12-31 | $2.74M | +17.21% | +133.02% |
| Q3 FY2024Period end 2024-09-30 | $2.34M | +0.09% | +114.90% |
| Q2 FY2024Period end 2024-06-30 | $2.33M | +37.54% | +17.82% |
| Q1 FY2024Period end 2024-03-31 | $1.70M | +44.43% | -1.91% |
| Q4 FY2023Period end 2023-12-31 | $1.18M | +8.10% | +42.42% |
| Q3 FY2023Period end 2023-09-30 | $1.09M | -45.13% | +49.52% |
| Q2 FY2023Period end 2023-06-30 | $1.98M | +14.51% | +232.38% |
| Q1 FY2023Period end 2023-03-31 | $1.73M | +109.70% | +387.32% |
| Q4 FY2022Period end 2022-12-31 | $825.00K | +13.48% | +65.33% |
| Q3 FY2022Period end 2022-09-30 | $727.00K | +21.98% | -26.19% |
| Q2 FY2022Period end 2022-06-30 | $596.00K | +67.89% | +11.19% |
| Q1 FY2022Period end 2022-03-31 | $355.00K | -28.86% | -52.41% |
| Q4 FY2021Period end 2021-12-31 | $499.00K | -49.34% | N/A |
| Q3 FY2021Period end 2021-09-30 | $985.00K | +83.77% | N/A |
| Q2 FY2021Period end 2021-06-30 | $536.00K | -28.15% | N/A |
| Q1 FY2021Period end 2021-03-31 | $746.00K | N/A | N/A |
| Q4 FY2020Period end 2020-12-31 | $0 | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
